Ashford Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,221
Closed -$494K 119
2018
Q2
$494K Buy
6,221
+240
+4% +$19.9K 0.07% 82
2018
Q1
$534K Buy
5,981
+433
+8% +$41.6K 0.08% 73
2017
Q4
$579K Sell
5,548
-219
-4% -$24.7K 0.09% 75
2017
Q3
$841K Buy
5,767
+271
+5% +$36.9K 0.14% 71
2017
Q2
$714K Buy
5,496
+1,111
+25% +$136K 0.12% 70
2017
Q1
$546K Buy
+4,385
New +$525K 0.1% 78
2015
Q4
Sell
-13,159
Closed -$1.42M 122
2015
Q3
$1.42M Buy
13,159
+49
+0.4% +$6.08K 0.33% 62
2015
Q2
$1.52M Sell
13,110
-1,590
-11% -$182K 0.33% 65
2015
Q1
$1.7M Sell
14,700
-9,600
-40% -$1.15M 0.35% 72
2014
Q4
$2.72M Buy
24,300
+300
+1% +$31.6K 0.54% 61
2014
Q3
$2.27M Hold
24,000
0.49% 66
2014
Q2
$2.06M Buy
24,000
+4,200
+21% +$319K 0.41% 72
2014
Q1
$1.38M Hold
19,800
0.27% 80
2013
Q4
$1.67M Hold
19,800
0.32% 74
2013
Q3
$1.53M Buy
19,800
+1,000
+5% +$70.1K 0.3% 75
2013
Q2
$1.1M Buy
+18,800
New +$1.13M 0.24% 82

Other funds holding CELG

Ashford Capital Management's CELG Position: Q3 2018 in Review

Ashford Capital Management sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 6,221 shares — an estimated $494K sold.

Ashford Capital Management first reported a position in CELG in Q2 2013 and held it in 16 quarters. The position peaked at $2.72M in Q4 2014. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Ashford Capital Management reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Ashford Capital Management sold 6,221 Celgene Corp shares in Q3 2018, an estimated $494K.
  • Ashford Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 16 quarters.
  • Ashford Capital Management's Celgene Corp position peaked at $2.72M in Q4 2014.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Ashford Capital Management's 13F filing for Q3 2018, filed 15 Nov 2018.